Cytoplasmic localization of ELAVL1 (embryonic lethal abnormal vision-like protein 1) and BRCA1 (breast cancer 1) gene mutations are associated with poor prognosis of breast cancer [43–46]. This evidence concerns the gene BRCA1 and breast carcinoma.